文献速递生殖医学妇科

子宫内膜异位症患者生育力保存的累计活产率与所需卵母细胞数

Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis.
PubMed 文献 · Reprod Biomed Online · 2021-01-08

该回顾性观察研究纳入485例子宫内膜异位症患者,分析卵母细胞玻璃化保存后的累计活产率(CLBR)。使用22枚卵母细胞时CLBR达89.5%(95%CI 80.0-99.1%),年轻患者(≤35岁)结局更优;与选择性生育力保存组相比,子宫内膜异位症组CLBR更高(89.5% vs 59.9%,P<0.00001)。

要点

  • 使用卵母细胞数增加,子宫内膜异位症患者累计活产率随之上升。
  • ≤35岁患者使用约20枚卵母细胞CLBR达95.4%,优于>35岁者的79.6%。
  • 使用22枚卵母细胞时,子宫内膜异位症组CLBR高于选择性生育力保存组。

核心结论

  • 子宫内膜异位症患者使用卵母细胞数越多,活产概率越高,年轻女性结局更佳。

研究设计与样本

  • 回顾性观察研究,纳入2007年1月至2018年7月期间接受生育力保存的485例子宫内膜异位症女性。
  • 采用生存曲线和Kaplan-Meier图分析累计活产率,并与选择性生育力保存患者作为对照组比较。

主要发现

  • 使用22枚卵母细胞时累计活产率达89.5%(95%CI 80.0-99.1%)。
  • 年轻组(≤35岁)使用约20枚卵母细胞累计活产率为95.4%(95%CI 87.2-103.6%),年长组(>35岁)为79.6%(95%CI 58.1-101.1%),log-rank P=0.002。
  • 选择性生育力保存组平均年龄更高(37.2±4.9岁 vs 35.7±3.7岁,P<0.001)。
  • 使用22枚卵母细胞时,子宫内膜异位症组累计活产率89.5%(95%CI 80.0-99.1%)高于选择性生育力保存组的59.9%(95%CI 51.4-68.6%),log-rank P<0.00001。

关键数值与推荐

  • 累计活产率随使用卵母细胞数增加而升高,使用22枚时达89.5%(95%CI 80.0-99.1%)。
  • 年轻女性(≤35岁)使用约20枚卵母细胞累计活产率95.4%(95%CI 87.2-103.6%),年长女性(>35岁)为79.6%(95%CI 58.1-101.1%)。

临床怎么用

  • 可为子宫内膜异位症患者提供生育力保存咨询时参考卵母细胞数量与累计活产率的关系。
  • 年轻患者可能以较少卵母细胞数获得较高累计活产率,年长患者需更多卵母细胞。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: How does the number of oocytes used affect the cumulative live birth rate (CLBR) in endometriosis patients who had their oocytes vitrified for fertility preservation? DESIGN: Retrospective observational study including data from 485 women with endometriosis who underwent fertility preservation from January 2007 to July 2018. Survival curves and Kaplan-Meier plots were used to analyse the CLBR according to the number of vitrified oocytes used. Endometriosis curves were compared with plots developed using elective fertility preservation (EFP) patients as control group. Log-rank, Breslow and Tarone-Ware tests were used to compare the survival curves. RESULTS: The CLBR increased as the number of oocytes used per patient rose, reaching 89.5% (95% confidence interval [CI] 80.0-99.1%) using 22 oocytes. Higher outcomes were observed in young women (≤35 years old versus >35 years old). In the younger group, the CLBR was 95.4% (95% CI 87.2-103.6%) using approximately 20 oocytes versus 79.6% (95% CI 58.1-101.1%) in older women (log-rank [Mantel-Cox] P = 0.002). The mean age was higher in EFP patients (37.2 ± 4.9 versus 35.7 ± 3.7; P < 0.001). The outcome was better in the endometriosis group as compared with EFP: a CLBR of 89.5% (95% CI 80.0-99.1%) versus 59.9% (95% CI 51.4-68.6%) when 22 oocytes were used (log-rank [Mantel-Cox] P < 0.00001). CONCLUSION: The probability of live birth increases as the number of oocytes used increases in patients with endometriosis, but better outcomes were observed among young women. The information provided here may be of interest to both patients and treating physicians for counselling purposes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Cobo A, Coello A, de Los Santos MJ, et al. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis. Reprod Biomed Online. 2021. PMID: 33573907. doi:10.1016/j.rbmo.2020.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。